Showing results (231-240 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|May 13, 2023
Cost-Effectiveness of Semaglutide vs. Empagliflozin, Canagliflozin, and Sitagliptin for Treatment of Patients with Type 2 Diabetes in Denmark: A Decision-Analytic Modelling StudyRyan Pulleyblank, Nikolaj Birk Larsen
Pharmacoeconomics - Open|August 22, 2022
The Cost of Flexible Bronchoscopes: A Systematic Review and Meta-analysisCarina Østervig Andersen, Helena Travis, Emilie Dehlholm-Lambertsen, et al.
Pharmacoeconomics - Open|September 17, 2021
Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver StatesSiu Hing Lo, Andrew Lloyd, Shuayb Elkhalifa, et al.
Pharmacoeconomics - Open|August 4, 2022
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in IrelandThomas Ward, Tray Brown, Ruth D Lewis, et al.
Pharmacoeconomics - Open|August 9, 2022
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in ColombiaFabio Gil, Fabian Juliao-Baños, Luisa Amador, et al.
Pharmacoeconomics - Open|March 23, 2023
Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD CountriesMackenzie Mills, Panos Kanavos
Pharmacoeconomics - Open|February 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung CancerAndre Verhoek, Parneet Cheema, Barbara Melosky, et al.
Pharmacoeconomics - Open|May 5, 2021
Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness AnalysesLiv Solvår Nymark, Alex Miller, Anna Vassall
Pharmacoeconomics - Open|March 15, 2023
Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for InfertilityChris Skedgel, Patricia Cubi-Molla, David Mott, et al.
Pharmacoeconomics - Open|November 16, 2025
Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in SpainIago Rodríguez-Lago, Fernando Muñoz Núñez, Alfredo J Lucendo, et al.
Pageof 61